Showing results (1171-1180 of 2,390) with videos related to

Sort By:
Pageof 239
The AAPS Journal|June 2, 2026
Context-of-use-Guided Development and Validation of a Transthyretin Immunoassay: A Framework for Biomarker Assay DesignTanya Watanabe, John Canfield, Erin Anderson, et al.
The AAPS Journal|May 29, 2026
New Frontiers of Drug Development Through the Use of New Approach MethodologiesM N Martinez, J P Mochel, K Allenspach, et al.
The AAPS Journal|May 27, 2026
Development and Implementation of a Hinderance-based In Vitro Model for Porous MembranesDaniel A Paterson, Lucy Coleman, Yuri Dancik, et al.
The AAPS Journal|April 6, 2022
An Investigation of Instability in Dried Blood Spot Samples for Pharmacokinetic Sampling in Phase 3 Trials of VerubecestatMelanie Anderson, Marissa F Dockendorf, Ian McIntosh, et al.
The AAPS Journal|April 6, 2006
The pharmacokinetics of escitalopram in patients with hepatic impairmentJohan Areberg, Jacob Strøyer Christophersen, Mette Nøhr Poulsen, et al.
The AAPS Journal|August 4, 2009
Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutionsRadojka M Savic, Mats O Karlsson
The AAPS Journal|May 7, 2026
Estimating Intragastric Disintegration Times of Immediate Release Dose Units Administered After a High-Calorie, High-Fat Meal Using Standardized, Commercially Available Equipment and MaterialsMaria Vertzoni, Erato Androulaki, Shirin Dietrich, et al.
The AAPS Journal|May 11, 2026
In-depth Characterization of Photo-Stressed Antibody-Drug Conjugates by Mass SpectrometryXiao Pan, Yimeng Zhao, Shukun Luo, et al.
The AAPS Journal|May 14, 2014
Nanomedicine drug development: a scientific symposium entitled "Charting a roadmap to commercialization"Gregory Finch, Henry Havel, Mostafa Analoui, et al.
The AAPS Journal|January 25, 2017
Scientific and Regulatory Considerations for Generic Complex Drug Products Containing NanomaterialsNan Zheng, Dajun D Sun, Peng Zou, et al.
Pageof 239